Beijing, Oct 26 (Prensa Latina) China began applying in Shanghai its indigenous Covid-19 nasal vaccine, developed by the CanSino Biologics pharmaceutical company, amid recurring outbreaks caused by the Omicron strain of the SARS-CoV-2.
States are spending billions of dollars of federal pandemic relief funds on infrastructure projects such as roads, bridges and public buildings, as reported by the Associated Press.